LTR 94: The road ahead for PCCPs and AI/ML amidst chaos at the FDA

This is a free preview of a paid episode. To hear more, visit naveenagarwalphd.substack.com

Summary

“The Digital Health Center of Excellence was hit pretty heavy, and also AI researchers at OSEL. I am not too worried about PCCP but the impact could be on how quickly FDA can finalize the other draft guidance with larger scope applied to all medical devices.”

In this episode of the Let's Talk Risk Podcast, Naveen Agarwal and Yu Zhao discuss the P…